Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors
RecruitingOBSERVATIONAL
Enrollment
45
Participants
Timeline
Start Date
October 21, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2028
Conditions
High-risk Neuroblastoma
Trial Locations (1)
38105
RECRUITING
St. Jude Children's Research Hospital, Memphis
All Listed Sponsors
lead
St. Jude Children's Research Hospital
OTHER
NCT06480526 - Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors | Biotech Hunter | Biotech Hunter